Quality of life is significantly reduced even in individuals with only mild visual impairment.
Has Diabetic Retinopathy Improved in Type 1 Diabetics Over the Years?

Changes in Visual Impairment Prevalence by Period of Diagnosis of Diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Klein R, Lee KE, et al: Ophthalmology 2009; 116 (October): 1937 116 (October): -1942 Improvements in glycemic control and modern therapy for the management of diabetic retinopathy have resulted in a significant reduction in visual impairment in type 1 diabetics.
Objective: To evaluate the relationship of the period of diagnosis of type 1 diabetes to the risk of developing visual impairment. Design: Population-based, longitudinal study. Participants: 955 individuals between the ages of 4 and 80 years at the time of baseline examination living in southern Wisconsin who were diagnosed with type 1 diabetes before the age of 30 were enrolled in the study. Methods: 5 eye examination visits took place during the period of 1980 through 2007. Individuals were categorized both by the duration of diabetes and the time period during which they were diagnosed with type 1 diabetes. Visual impairment was defined as best-corrected visual acuity of 20/40 or worse in the better-seeing eye. Statistical analysis allowed the evaluation of both duration of diabetes and the time at which diabetes was diagnosed as risk factors for visual impairment. Disc hemorrhages are associated with an accelerated rate of visual field loss within the sector corresponding to the disc hemorrhage.
Objective: To evaluate global and focal visual field progression before and after the occurrence of an optic disc hemorrhage. Design: Retrospective, observational clinical case series. Methods: A large clinical database from a glaucoma specialty practice was searched to identify patients with open-angle glaucoma who had at least 5 SITA-standard 24-2 Humphrey visual fields in either eye. The optic disc photographs of patients were then reviewed to identify individuals who had a disc hemorrhage during the period of visual field follow-up. Point-wise linear regression analysis was performed on the series of visual fields to determine global and focal rates of glaucoma progression before and after the occurrence of the disc hemorrhage. The contralateral eyes of individuals with unilateral disc hemorrhage were also evaluated to compare the rate of visual field progression to that of eyes with disc hemorrhage. Results: 168 disc hemorrhages were identified in 122 patients. The mean patient age was 68.9 ± 11.2 years. The mean number of visual field tests was 9.0, spanning an average of 6.7 years. The mean rate of global progression of visual field loss before and after a disc hemorrhage was -0.6 ± 0.8 dB/y and 1.0 ± 1.2 dB/y, indicating more rapid progression of visual field loss after the disc hemorrhage. The mean rate of progression within the sector corresponding to disc hemorrhage before and after its detection was -2.0 ± 1.0 and -3.7 ± 3.6 dB/y, indicating more rapid progression within the sector both before and after disc hemorrhage. The rate of global and sectoral visual field loss was greater in eyes with disc hemorrhage than in contralateral control eyes without a disc hemorrhage. Conclusions: Localized visual field loss is more rapid in regions corresponding to a disc hemorrhage, indicating that a disc hemorrhage is a clear sign of visual field instability in patients with open-angle glaucoma. Reviewer's Comments: This study provides compelling evidence that disc hemorrhages represent a lack of stability of glaucoma and must be considered as a sign of glaucoma progression. Hemorrhages should be sought on follow-up examination with all glaucoma patients and must be acted on to prevent further glaucoma progression and loss of visual function. (Reviewer-Scott D. Smith, MD, MPH).
Should Older Glaucoma Patients Still Be Driving?
Driving In older adults, glaucoma is associated with an increased probability of driving cessation.
Objective: To determine the relationship between glaucoma and driving limitation or cessation in an older adult population. Design: A cross-sectional analysis of a longitudinal, population-based cohort study. Methods: Individuals enrolled in the population-based Salisbury Eye Evaluation Project who reported having obtained a driver's license at any time in their life were included in this analysis. The diagnosis of glaucoma was made on the basis of a comprehensive eye examination, including optic disc examination and visual field testing. Driving habits of subjects were evaluated based on a questionnaire administered by an interviewer. Questions included whether driving cessation had taken place, and, if so, when and whether vision was related to the decision to discontinue driving. Subjects were classified on the basis of having no glaucoma, unilateral glaucoma, or bilateral glaucoma, which was then evaluated with regard to driving habits. Results: 15% of subjects without glaucoma reported driving cessation by the end of the cohort study. In contrast, 21% of unilateral glaucoma subjects and 41% of bilateral glaucoma subjects reported driving cessation. Multivariate analysis adjusting for potential confounding factors confirmed that glaucoma diagnosis was associated with driving cessation. Conclusions: Glaucoma diagnosis is associated with a significantly increased rate of driving cessation in older adults. Reviewer's Comments: Although the association was weaker, indications that even unilateral glaucoma was associated with driving cessation in this elderly adult population were present. Clearly, bilateral glaucoma was associated with a considerably higher risk of driving cessation, indicating the importance of glaucoma on visual function and maintaining independence in older adults. Knowledge of this association may help patients become motivated to adhere to medical therapy to maintain their independence as they reach older age.
(Reviewer-Scott D. Smith, MD, MPH).
IOP--Can We Estimate Its Characteristics During Office Hours?
The Measurements were made at 9 AM, 12, 3, 6, and 9 PM, and 12, 3, and 6 AM in both the sitting and the supine positions. Sitting measurements were made with a Goldmann applanation tonometer, and supine measurements were made with the TonoPen. Statistical analysis was performed to determine whether the sitting, supine, or a combination of both sitting and supine IOP measurements most accurately predicted the 24-hour peak IOP. Results: In glaucoma patients, the peak IOP occurred outside of office hours in 42% of cases, while in control subjects, peak IOP occurred outside of office hours in >62% of cases. Although combining sitting and supine IOP measurements made during office hours did not improve the prediction of the mean 24-hour IOP, the average of the sitting and supine peak IOP taken during office hours more accurately reflected the peak 24-hour IOP. Conclusions: Compared with using measurements made in the sitting position alone, the measurement of both supine and sitting IOP during office hours may improve the prediction of the true 24-hour peak IOP in both control subjects and patients with glaucoma. Reviewer's Comments: Further study is needed to determine exactly how IOP assessment during office hours can best reflect variability in IOP throughout the day. This study, however, suggests that making measurements both in the sitting and supine position offers some benefit in correctly interpreting IOP readings in patients in whom diurnal IOP measurements are needed. (Reviewer-Scott D. Smith, MD, MPH).
VEGF Neutralization May Improve Results of High-Risk Corneal Transplantation
Transient Postoperative Vascular Endothelial Growth Factor (VEGF)-Neutralisation Improves Graft Survival in Corneas With Partly Regressed Inflammatory Neovascularisation.
Bachmann BO, Luetjen-Drecoll E, et al: Ophthalmol 2009; 93 (August): 1075 93 (August): -1080 Inhibition of VEGF can reduce reactivation of previously regressed corneal neovascularization and may improve the results of high-risk corneal transplantation.
Objective: To investigate the effect of vascular endothelial growth factor (VEGF) inhibition on the survival of corneal grafts performed in the presence of regressed corneal neovascularization in an animal model. Design: In vivo laboratory experiment. Methods: Corneal limbal neovascularization was induced by placement of three 11-0 nylon sutures at the corneoscleral limbus of 6-to 8-week-old mice. The sutures were left in place for 6 weeks. Six months after removal of the sutures, significant regression of neovascularization had occurred. Corneal grafting was performed, and the animals were divided into a treatment and control group. The treatment group received an intraperitoneal injection of VEGF-A specific cytokine trap (VEGF-trap) 4 times during the first 2 weeks after graft placement. The other group had no additional treatment.
Results: 3 days after surgery, significantly less re-activation of previously regressed corneal neovascularization was observed in animals that received the VEGF-trap treatment in comparison to control animals. In addition, graft survival at 8 weeks was significantly greater in VEGF-trap-treated animals (36% vs 9%; P <0.05). Conclusions: VEGF inhibition in animal eyes with regressed corneal neovascularization significantly reduces corneal revascularization and improves graft survival. Reviewer's Comments: This study demonstrates the potential of VEGF inhibition in improving the results of corneal transplantation in eyes that are at high risk for graft failure. Patients with corneal opacity due to trauma, herpetic keratitis, and other inflammatory conditions often have corneal neovascularization. Even when this neovascularization has regressed prior to surgery reactivation of these abnormal vessels can significantly reduce the likelihood of a good clinical outcome. This study demonstrates that inhibition of VEGF during the inflammatory phase following surgery can reduce this reactivation of regressed neovascularization and shows promise in improving the results of high risk corneal transplantation. (Reviewer-Scott D. Smith, MD, MPH).
